Advanced search
Publication Cover
Drug Delivery Volume 25, 2018 - Issue 1
Submit an article Journal homepage
2,187
Views
29
CrossRef citations to date
0
Altmetric
Research Article

Borneol and Α-asarone as adjuvant agents for improving blood–brain barrier permeability of puerarin and tetramethylpyrazine by activating adenosine receptors

Jun-Yong WuDepartment of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China; ;Institute of Clinical Pharmacy, Central South University, Changsha, Hunan, China; ;Hunan Provincial Engineering Research Center of Translational Medicine and Innovative Drug, Changsha, Hunan Province, ChinaView further author information
,
Yong-Jiang LiDepartment of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China; ;Institute of Clinical Pharmacy, Central South University, Changsha, Hunan, China; ;Hunan Provincial Engineering Research Center of Translational Medicine and Innovative Drug, Changsha, Hunan Province, ChinaORCID Iconhttp://orcid.org/0000-0001-6882-7862View further author information
ORCID Icon,
Le YangDepartment of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China; ;Institute of Clinical Pharmacy, Central South University, Changsha, Hunan, China; ;Hunan Provincial Engineering Research Center of Translational Medicine and Innovative Drug, Changsha, Hunan Province, ChinaView further author information
,
Yi-Yun HuDepartment of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China; ;Institute of Clinical Pharmacy, Central South University, Changsha, Hunan, China; ;Hunan Provincial Engineering Research Center of Translational Medicine and Innovative Drug, Changsha, Hunan Province, ChinaView further author information
,
Xiong-Bin HuDepartment of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China; ;Institute of Clinical Pharmacy, Central South University, Changsha, Hunan, China; ;Hunan Provincial Engineering Research Center of Translational Medicine and Innovative Drug, Changsha, Hunan Province, ChinaView further author information
,
Tian-Tian TangDepartment of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China; ;Institute of Clinical Pharmacy, Central South University, Changsha, Hunan, China; ;Hunan Provincial Engineering Research Center of Translational Medicine and Innovative Drug, Changsha, Hunan Province, ChinaView further author information
,
Jie-Min WangDepartment of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China; ;Institute of Clinical Pharmacy, Central South University, Changsha, Hunan, China; ;Hunan Provincial Engineering Research Center of Translational Medicine and Innovative Drug, Changsha, Hunan Province, ChinaView further author information
,
Xin-Yi LiuDepartment of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China; ;Institute of Clinical Pharmacy, Central South University, Changsha, Hunan, China; ;Hunan Provincial Engineering Research Center of Translational Medicine and Innovative Drug, Changsha, Hunan Province, ChinaView further author information
&
Da-Xiong XiangDepartment of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China; ;Institute of Clinical Pharmacy, Central South University, Changsha, Hunan, China; ;Hunan Provincial Engineering Research Center of Translational Medicine and Innovative Drug, Changsha, Hunan Province, ChinaCorrespondence[email protected]
View further author information
 show all
Pages 1858-1864 | Received 11 Jul 2018, Accepted 21 Aug 2018, Published online: 19 Oct 2018

References

  • Abbott NJ, Patabendige AaK, Dolman DEM, et al. (2010). Structure and function of the blood–brain barrier. Neurobiol Dis 37:13–25.
  • Cai Z, Lei X, Lin Z, et al. (2014). Preparation and evaluation of sustained-release solid dispersions co-loading gastrodin with borneol as an oral brain-targeting enhancer. Acta Pharm Sin B 4:86–93.
  • Carman AJ, Mills JH, Krenz A, et al. (2011). Adenosine Receptor Signaling Modulates Permeability of the Blood–brain Barrier. J Neurosci 31:13272–80.
  • Carman CV, Springer TA. (2008). Trans-cellular migration: cell-cell contacts get intimate. Curr Opin Cell Biol 20:533–40.
  • Fredholm BB, Ijzerman AP, Jacobson KA, et al. (2011). International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors-an update. Pharmacol Rev 63:1–34.
  • Fu BM. (2012). Experimental methods and transport models for drug delivery across the blood–brain barrier. CPB 13:1346–59.
  • Garcia-Garcia E, Andrieux K, Gil S, Couvreur P. (2005). Colloidal carriers and blood–brain barrier (BBB) translocation: a way to deliver drugs to the brain? Int J Pharm 298:274–92.
  • Haseloff RF, Dithmer S, Winkler L, et al. (2015). Transmembrane proteins of the tight junctions at the blood–brain barrier: structural and functional aspects. Semin Cell Dev Biol 38:16–25.
  • Huber JD, Egleton RD, Davis TP. (2001). Molecular physiology and pathophysiology of tight junctions in the blood–brain barrier. Trends Neurosci 24:719–25.
  • Kim DG, Bynoe MS. (2015). A2A Adenosine receptor regulates the human blood–brain barrier permeability. Mol Neurobiol 52:664–78.
  • Li W, Wu J, Zhang J, et al. (2018). Puerarin-loaded PEG-PE micelles with enhanced anti-apoptotic effect and better pharmacokinetic profile. Drug Deliv 25:827–37.
  • Liu RN, Xing DM, Lu H, et al. (2006). Pharmacokinetics of puerarin and ginsenoside Rg1 of CBN injection and the relation with platelet aggregation in rats. Am J Chin Med 34:1037–45.
  • Sheu JR, Kan YC, Hung WC, et al. (2000). The antiplatelet activity of tetramethylpyrazine is mediated through activation of NO synthase. Life Sci 67:937–47.
  • Sun YW, Jiang J, Zhang ZJ, et al. (2008). Antioxidative and thrombolytic TMP nitrone for treatment of ischemic stroke. Bioorg Med Chem 16:8868–74.
  • Tornavaca O, Chia M, Dufton N, et al. (2015). ZO-1 controls endothelial adherens junctions, cell-cell tension, angiogenesis, and barrier formation. J Cell Biol 208:821–38.
  • Wang JW, Wang HD, Cong ZX, et al. (2014a). Puerarin ameliorates oxidative stress in a rodent model of traumatic brain injury. J Surg Res 186:328–37.
  • Wang LP, Feng JF, Hu KL. (2014b). Progress in regulation effect of aromatic refreshing traditional Chinese medicine on BBB permeability and its mechanism. Zhongguo Zhong Yao Za Zhi 39:949–54.
  • Wang N, Zhang YM, Wu L, et al. (2014c). Puerarin protected the brain from cerebral ischemia injury via astrocyte apoptosis inhibition. Neuropharmacol 79:282–9.
  • Wei SY, Chen Y, Xu XY. (2014). Progress on the pharmacological research of puerarin: a review. Chin J Nat Med 12:407–14.
  • Wu XD, Wang C, Zhang ZY, et al. (2014). Puerarin attenuates cerebral damage by improving cerebral microcirculation in spontaneously hypertensive rats. Evid Based Complement Alternat Med 2014:1.
  • Yang S, Zhang X, Xiang D. (2016). Comparison of pharmacokinetics of NaoDeSheng oral microemulsion and tablets. Chin Hosp Pharm J 36:728–31.
  • Yi T, Tang DD, Wang F, et al. (2017). Enhancing both oral bioavailability and brain penetration of puerarin using borneol in combination with preparation technologies. Drug Deliv 24:422–9.
  • Yuan Y, Zong J, Zhou H, et al. (2014). Puerarin attenuates pressure overload-induced cardiac hypertrophy. J Cardiol 63:73–81.
  • Zhang QL, Fu BMM, Zhang ZJ. (2017). Borneol, a novel agent that improves central nervous system drug delivery by enhancing blood–brain barrier permeability. Drug Deliv 24:1037–44.
  • Zhang X, Xiong J, Liu S, et al. (2014). Puerarin protects dopaminergic neurons in Parkinson’s disease models. Neurosci 280:88–98.
  • Zhong YF, Zhang XW, Cai XF, et al. (2014). Puerarin attenuated early diabetic kidney injury through down-regulation of matrix metalloproteinase 9 in streptozotocin-induced diabetic rats. Plos One 9:e85690.
  • Zhu YQ, Yu J, Meng FH, et al. (2018). Highly efficacious and specific anti-glioma chemotherapy by tandem nanomicelles co-functionalized with brain tumor-targeting and cell-penetrating peptides. J Controlled Release 278:1–8.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.